Drugs for Neglected Diseases Initiative
The Drugs for Neglected Diseases initiative is a collaborative, patients' needs-driven, non-profit drug research and development organization that is developing new treatments for neglected diseases, notably leishmaniasis, sleeping sickness, Chagas disease, malaria, filarial diseases, mycetoma, paediatric HIV, cryptococcal meningitis, hepatitis C, and dengue. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Drugs for Neglected Diseases Initiative, Switzerland, covering academic research published from 2003 to 2023. Read More.
Open Access Percentage
84%
Total
Publications
694
Total Open
Publications
583
Total
Citations
31K
Open Access
Percentage
84%
Total
Publications
694
Total Open
Publications
583
Total
Citations
31K
Breakdown
Publisher Open
10%
Both
63%
Other Platform Open
11%
Closed
16%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 58%
294
Hybrid 30%
153
No Guarantees 12%
59
Other Platform Open
Domain 81%
418
Institution 46%
238
Other Internet 13%
69
Public 13%
68
Preprint 10%
53
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 418 |
Europe PMC | Domain | 225 |
Semantic Scholar | Public | 56 |
University College London - UCL Discovery | Institution | 38 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 37 |
lshtm.ac.uk OAI-PMH Repository | Institution | 34 |
London School of Hygiene and Tropical Medicine - LSHTM Research Online | Institution | 34 |
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia | Other Internet | 30 |
Erasmus University Rotterdam - EUR Research Repository | Institution | 23 |
DOI | Other Internet | 23 |